Clinical trial Recruiting at 1 site Observational Ages 18 to 80

Evaluating the GEMINI SL Knee Prosthesis for Osteoarthrosis

Official title: Clinical and Functional Outcome of the GEMINI SL Fixed Bearing PS Knee Prosthesis in Short-, Mid-, and Longterm Follow-up

Run by Waldemar Link GmbH & Co. KG · NCT04858347 · Data updated 2026-11-12

This study is testing how well the GEMINI SL knee prosthesis works and stays safe for people with osteoarthrosis over a 10-year period.

Quick facts

Study typeObservational
Ages18 Years to 80 Years
SexAll
Enrollment350 (estimated)
SponsorWaldemar Link GmbH & Co. KG
Industry-sponsored
Locations1 site (Cali, Valle del Cauca Department)
StatusRecruiting
StartedJuly 4, 2019
Main results expectedOctober 2034
Study endsOctober 2035
Registry record updatedJanuary 12, 2023
Trial IDNCT04858347 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals aged 18 to 80 who require a total knee replacement and are undergoing implantation of the GEMINI SL Fixed Bearing PS knee prosthesis.

Probably not a fit

Patients with a BMI over 40 kg/m², significant comorbidities affecting outcomes, or those who are mentally unable to understand the study will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the long-term safety and performance of the GEMINI SL Fixed Bearing PS knee prosthesis over a planned follow-up period of 10 years. It will involve multiple centers and focus on the 10-year survival rate of the prosthesis, with revision for any reason as the primary endpoint. The study seeks to generate clinical data under routine conditions, as there is currently a lack of mid- and long-term data for this specific knee prosthesis.

Why it matters

Potential benefit: If successful, this study could provide valuable insights into the long-term effectiveness and safety of the GEMINI SL knee prosthesis for patients with knee osteoarthrosis.

How similar studies have gone: While this study is focused on a specific prosthesis, similar observational studies have successfully provided long-term data on knee replacements, indicating potential for valuable insights.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Signed patient informed consent
* Implantation of a GEMINI SL Fixed Bearing PS knee prosthesis
* Age between 18 and 80 years

Exclusion Criteria:

* Body Mass Index (BMI) \> 40 kg/m²
* Foreseeable life expectancy under 5 years
* Comorbidities and known medical circumstances which would affect the clinical or functional outcome after implantation of the knee prosthesis (e.g. neurological or musculoskeletal diseases) at the time of implantation
* Patient who is mentally not able to understand the study and the study conduct
* Patients who will be foreseeable non-compliant to the planned routine interventions and study related follow-ups
* Prisoner
* Pregnant women

Where it's running

  • Centro Medico Imbanaco Sede Principal
    Cali, Valle del Cauca Department, Colombia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Evaluating the MobileLink Hip Prosthesis System Outcomes

    This study is looking at how well the MobileLink hip replacement system works and how satisfied patients are after getting it.

    Recruiting at 2 sites Waldemar Link GmbH & Co. KG · Kiel and 1 other locations · NCT04688593

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.